Kidney Cancer
📧 Sign up to get email alerts when something new happens for Kidney Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-06-22Clinical Trial Update: Radiation Therapy in Treating Patients With Newly Diagnosed Brain Metastases From Kidney Cancer, Melanoma, or Sarcoma [Phase 2]
Phase 2 clinical trial update evaluating radiation therapy for newly diagnosed brain metastases from kidney cancer, melanoma, or sarcoma.
-
CLINICAL_TRIALS trial_result · 2023-06-22Clinical Trial Update: Atrasentan in Treating Patients With Locally Recurrent or Metastatic Kidney Cancer [Phase 2]
Phase 2 clinical trial update for atrasentan in locally recurrent or metastatic kidney cancer.
-
CLINICAL_TRIALS trial_result · 2023-06-18Clinical Trial Update: Paclitaxel and Carboplatin in Treating Patients With Locally Advanced or Metastatic Renal Cell Cancer [Phase 2]
Phase 2 clinical trial evaluating paclitaxel and carboplatin for locally advanced or metastatic kidney cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-03-29Clinical Trial Update: Denosumab and Pembrolizumab in Clear Cell Renal Carcinoma [Phase 2]
Phase 2 trial investigating denosumab with pembrolizumab in clear cell renal cell carcinoma (metastatic).
-
CLINICAL_TRIALS trial_result · 2023-03-21Clinical Trial Update: A Phase 2 Study of the MET Kinase Inhibitor INC280 in Papillary Renal Cell Cancer [Phase 2]
Phase 2 study of the MET kinase inhibitor INC280 (epernestib) in papillary renal cell cancer has completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-08-08Clinical Trial Update: Tislelizumab Plus Lenvatinib in Stage III-IV RCC [Phase 2]
A Phase 2 trial updating tislelizumab plus lenvatinib in advanced kidney cancer is underway; results are currently unknown.
-
CLINICAL_TRIALS trial_result · 2022-04-27Clinical Trial Update: Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors [Phase 1, Phase 2]
Phase 1/Phase 2 trial investigating dasatinib combined with ifosfamide, carboplatin, and etoposide in young patients with metastatic or recu…
-
CLINICAL_TRIALS trial_result · 2022-03-18Clinical Trial Update: Tretinoin Plus Interferon Alfa in Treating Patients With Metastatic Kidney Cancer [Phase 2]
Phase 2 trial update evaluating tretinoin in combination with interferon alfa for metastatic kidney cancer has completed, with results poste…
-
CLINICAL_TRIALS trial_result · 2022-03-02Clinical Trial Update: A Study of QL1706 Plus Lenvatinib in Subjects With Advanced Renal Cell Carcinoma(RCC) [Phase 1, Phase 2]
Clinical trial update for QL1706 plus lenvatinib in advanced renal cell carcinoma (Phase 1/2) with unknown status.
-
CLINICAL_TRIALS trial_result · 2022-02-17Clinical Trial Update: Study of Durvalumab and Guadecitabine in Advanced Kidney Cancer [Phase 1, Phase 2]
Investigator-initiated trial evaluating durvalumab and guadecitabine in advanced kidney cancer (Phase 1/2; status: active not recruiting).
-
CLINICAL_TRIALS trial_result · 2022-01-05Clinical Trial Update: Monoclonal Antibody Therapy in Treating Patients With Advanced Kidney Cancer [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating a monoclonal antibody therapy for advanced kidney cancer has completed, with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2021-11-23Clinical Trial Update: Study Comparing Denosumab With Standard Treatment in Urothelial Cancer Patients With Bone Metastases [Phase 2]
Phase 2 trial comparing denosumab with standard treatment in urothelial cancer patients with bone metastases has completed.
-
CLINICAL_TRIALS trial_result · 2021-09-20Clinical Trial Update: Pazopanib Versus Temsirolimus in Poor-Risk Clear-Cell Renal Cell Carcinoma (RCC) [Phase 2]
Phase 2 trial comparing pazopanib to temsirolimus in poor-risk clear-cell renal cell carcinoma has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-06-01Clinical Trial Update: A Phase 1/2, Open-label Study to Evaluate the Safety and Antitumor Activity of MEDI0680 (AMP-514) in Combination With Durvalumab Versus Nivolumab Monotherapy in Participants With Select Advanced Malignancies [Phase 1, Phase 2]
Phase 1/2 open-label study evaluating MEDI0680 (AMP-514) with durvalumab vs nivolumab monotherapy in select advanced malignancies, including…
-
CLINICAL_TRIALS trial_result · 2021-05-14Clinical Trial Update: Safety Study With the Antibody, cG250, and Isotope, 124-Iodine, to Diagnose Patients With Renal Masses. [Phase 1]
Phase 1 safety study assessing cG250 antibody labeled with 124-Iodine for diagnosing renal masses has been completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-04-28Clinical Trial Update: Everolimus Versus Sunitinib in Non-Clear Cell Renal Cell Carcinoma [Phase 2]
Phase 2 trial comparing everolimus to sunitinib in non-clear cell renal cell carcinoma was terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2021-04-26Clinical Trial Update: A BIOmarker Driven Trial With Nivolumab and Ipilimumab or VEGFR tKi in Naïve Metastatic Kidney Cancer [Phase 2]
Phase 2 trial evaluating a biomarker-driven strategy with nivolumab plus ipilimumab or VEGFR TKI in first-line clear cell metastatic renal c…
-
CLINICAL_TRIALS trial_result · 2021-04-19Clinical Trial Update: Effect of Papaverine on Renal Artery Blood Flow Volume [Phase 4]
Phase 4 trial evaluating the effect of papaverine on renal artery blood flow volume in kidney cancer; study completed.
-
CLINICAL_TRIALS trial_result · 2021-04-13Clinical Trial Update: Sunitinib Malate With or Without Gemcitabine Hydrochloride in Treating Patients With Advanced Kidney Cancer That Cannot Be Removed By Surgery [Phase 2]
Phase 2 trial evaluating sunitinib with or without gemcitabine in advanced, unresectable kidney cancer.
-
CLINICAL_TRIALS trial_result · 2021-03-30Clinical Trial Update: SBRT (Stereotactic Body Radiation Therapy) in Combination With Nivolumab/Ipilimumab in Renal Cell Carcinoma (RCC) / Kidney Cancer Patients [Phase 2]
Phase 2 trial evaluating SBRT with nivolumab/ipilimumab in metastatic/Stage IV kidney cancer has completed with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-02-25Clinical Trial Update: Combination Chemotherapy Alone or With Radiation Therapy in Treating Children With Kidney Cancer [Phase 3]
Phase 3 trial comparing combination chemotherapy alone versus with radiation therapy in pediatric kidney cancer has completed.
-
CLINICAL_TRIALS trial_result · 2021-02-24Clinical Trial Update: Allogeneic Stem Cell Transplant in Treating Patients With Metastatic Kidney Cancer [Phase 2]
Phase 2 trial update on allogeneic stem cell transplant for metastatic kidney cancer completed.
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: Sunitinib as First-Line Therapy in Treating Patients With Locally Advanced Metastatic Papillary Renal Cell Cancer [Phase 2]
Phase 2 trial evaluating sunitinib as first-line therapy for locally advanced/metastatic papillary renal cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: Combination Chemotherapy in Treating Patients With Metastatic Kidney Cancer [Phase 2]
Phase 2 clinical trial update evaluating combination chemotherapy in metastatic kidney cancer has completed.
-
CLINICAL_TRIALS trial_result · 2020-07-22Clinical Trial Update: Radiosurgery in Treating Patients With Kidney Tumors [NA]
Clinical trial updating results for radiosurgery in kidney tumors has completed with results posted.